Inventor
JOHNSSON MARKUS
SE35 patents
⚠️ This page may combine multiple inventors who share the name “JOHNSSON MARKUS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CAMURUS AB
19 patentsUS9585959B2Mar 7, 2017
Robust controlled-release formulations
CAMURUS AB16 citations92
US9526788B2Dec 27, 2016
Pharmaceutical lipid compositions
CAMURUS AB8 citations84
US10912772B2Feb 9, 2021
Opioid formulations
CAMURUS AB4 citations83
US9937164B2Apr 10, 2018
Opioid formulations
CAMURUS AB7 citations83
US10688148B2Jun 23, 2020
Formulations containing a somatostatin receptor agonist
CAMURUS AB7 citations82
US9555118B2Jan 31, 2017
Robust controlled-release peptide formulations
CAMURUS AB5 citations73
US11135215B2Oct 5, 2021
Opioid formulations
CAMURUS AB3 citations72
US11110084B2Sep 7, 2021
Opioid formulations
CAMURUS AB2 citations72
US11564968B2Jan 31, 2023
Formulations containing a somatostatin receptor agonist
CAMURUS AB1 citations71
US11241476B2Feb 8, 2022
Mixtures and formulations comprising an alkyl ammonium EDTA salt
CAMURUS AB1 citations71
US11135264B2Oct 5, 2021
Formulations containing a somatostatin receptor agonist
CAMURUS AB3 citations71
US12396944B2Aug 26, 2025
Injectable buprenorphine formulation
CAMURUS AB0 citations62
US12318379B2Jun 3, 2025
Opioid formulations
CAMURUS AB0 citations62
US12161640B2Dec 10, 2024
Opioid formulations
CAMURUS AB1 citations62
US12029813B2Jul 9, 2024
Injectable buprenorphine formulation
CAMURUS AB1 citations62
US11672843B2Jun 13, 2023
Somatostatin receptor agonist formulations
CAMURUS AB1 citations62
US12257282B2Mar 25, 2025
Mixtures and formulations
CAMURUS AB0 citations61
US11369617B2Jun 28, 2022
Prostacyclin analogue formulations
CAMURUS AB0 citations61
US12246055B2Mar 11, 2025
Lipid-controlled release compositions
CAMURUS AB0 citations47
JOHNSSON MARKUS
5 patentsUS8541400B2Sep 24, 2013
Compositions forming non-lamellar dispersions
JOHNSSON MARKUS60 citations97
US8097239B2Jan 17, 2012
Controlled-release formulations
JOHNSSON MARKUS42 citations93
US8182834B2May 22, 2012
Ternary non-lamellar lipid compositions
JOHNSSON MARKUS16 citations76
US9974861B2May 22, 2018
Peptide slow-release formulations
JOHNSSON MARKUS4 citations71
US9060935B2Jun 23, 2015
Pharmaceutical lipid compositions
JOHNSSON MARKUS0 citations51
JOABSSON FREDRIK
4 patentsUS8546326B2Oct 1, 2013
Glp-1 analogue formulations
JOABSSON FREDRIK28 citations91
US9067190B2Jun 30, 2015
Method for loading amphiphile particles with active agents
JOABSSON FREDRIK2 citations61
US8871712B2Oct 28, 2014
Somatostatin analogue formulations
JOABSSON FREDRIK2 citations57
US9757461B2Sep 12, 2017
GnRH analogue formulations
JOABSSON FREDRIK0 citations51